Kenvue Inc. (KVUE)
NYSE: KVUE · Real-Time Price · USD
16.42
+0.25 (1.55%)
At close: Sep 26, 2025, 4:00 PM EDT
16.42
0.00 (-0.02%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Kenvue Revenue
Kenvue had revenue of $3.84B in the quarter ending June 29, 2025, a decrease of -4.03%. This brings the company's revenue in the last twelve months to $15.14B, down -2.16% year-over-year. In the year 2024, Kenvue had annual revenue of $15.46B with 0.07% growth.
Revenue (ttm)
$15.14B
Revenue Growth
-2.16%
P/S Ratio
2.08
Revenue / Employee
$688,227
Employees
22,000
Market Cap
31.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 15.46B | 11.00M | 0.07% |
Dec 31, 2023 | 15.44B | 494.00M | 3.30% |
Jan 1, 2023 | 14.95B | -104.00M | -0.69% |
Jan 2, 2022 | 15.05B | 587.00M | 4.06% |
Jan 3, 2021 | 14.47B | 143.00M | 1.00% |
Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 693.15B |
Costco Wholesale | 275.24B |
PepsiCo | 91.75B |
The Procter & Gamble Company | 84.28B |
Unilever | 70.19B |
Anheuser-Busch InBev | 58.52B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 39.06B |
KVUE News
- 20 hours ago - Kenvue: Trump-Era Volatility Presents A More Attractive Opportunity, But Headwinds Remain - Seeking Alpha
- 1 day ago - The CEO behind Tylenol thought he'd found a way to work with the Trump administration. Then everything went off the rails. - WSJ
- 1 day ago - Trump repeats Tylenol and vaccine claims, defying medical community outcry - Reuters
- 1 day ago - 51 September S&P Hi-Yield Aristocrats: 5 To Buy - Seeking Alpha
- 1 day ago - RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next? - Forbes
- 3 days ago - Attorneys urge court overseeing Tylenol autism lawsuits to consider Trump administration's stance - Reuters
- 3 days ago - RFK Jr.'s team wanted to tout an autism therapy. But a meeting with Tylenol's maker convinced the U.S. health secretary to put the emphasis on acetaminophen - WSJ
- 3 days ago - Kenvue: This Too Shall Pass - Seeking Alpha